Answers are grounded in this paper and cite their sources.
A novel platinum(II) photocaged complex called [Pt(cage)] has been prepared and characterized by X‐ray crystallography. The complex contains a photolabile nitrophenyl group incorporated into the backbone of a tetradentate ligand that contains two pyridyl and two amide nitrogen donor sites. The intact complex is unreactive toward ligand‐exchange reactions until activation with UV light cleaves the ligand backbone, releasing a Pt II complex that more readily exchanges its ligands, as verified by reaction with a methionine‐containing peptide. [Pt(cage)] is non‐toxic to MCF‐7 cells in the dark, whereas brief UV exposure induces cell death of human breast cancer MCF‐7 cells at a level approaching that of cisplatin. By using light to alter the coordination chemistry around the metal center, [Pt(cage)] represents a new strategy for potentially delivering metal‐based drugs in a site and time specific manner.
No takes yet. Share an insight, caveat, or question.
Ciesienski et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: